Satellite Symposia

Paradigm has extensive experience developing and implementing satellite symposia at a variety of meetings for specialty medical, pharmacy, and nursing audiences, as well as multi-disciplinary groups. We leverage our relationships with nationally renowned faculty to provide participants with access to experts in research and clinical practice. Incorporating interactive case-based discussions, faculty panels, and question-and-answer periods with timely didactic lectures actively engages learners, facilitating better application of information into everyday practice after participants leave the meeting. Our logistical agility and attention to detail help to create valuable and enjoyable learning experiences, contributing to participant and faculty satisfaction as well as return on education.

To browse our live activities and find one near you, please click here

EXPERT STRATEGIES FOR FACIAL REJUVENATION UTILIZING LONGER-ACTING DERMAL FILLERS

In the demanding field of aesthetic medicine, insufficient knowledge and skills can contribute to improper treatment and inferior patient outcomes with regard to efficacy and safety. A significant gap exists between the need for quality education and training for those interested in advanced practice of facial rejuvenation and the expert training that is currently available. This is especially true regarding longer-lasting soft tissue fillers. Clinicians clearly want and need additional education on the safe and effective use of these agents. This CME-certified activity will pay particular attention to advanced uses of longer-lasting soft tissue fillers as a fundamental component of individualized facial rejuvenation.

 

EMERGING THERAPIES IN THE TREATMENT OF MILD-TO-MODERATE ATOPIC DERMATITIS

This initiative consists of a series of live satellite symposia and an enduring webinar that includes video of faculty presentations synced with PowerPoint slides along with embedded interactive polling questions. These activities provide dermatology clinicians with relevant information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can help guide treatment selection. Expert faculty discuss the recent guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes.

 

INDIVIDUALIZING TYPE 2 DIABETES TREATMENT: APPLYING THE LATEST EVIDENCE IN CONSIDERATION OF PATIENT CHARACTERISTICS

A 2-hour, live satellite symposium will feature practical, evidence-based insights by recognized expert clinicians on how to implement guidelines for individualizing T2DM management, evaluate benefit/risk profiles of newer T2DM therapies, and assess effects of newer T2DM therapies on macrovascular (eg, atherosclerotic cardiovascular disease) and microvascular (eg, chronic kidney disease) outcomes. Included in the agenda are didactic lectures, interactive case studies, and a faculty Q&A session. The symposium will be enhanced by an audience response system feature, which allows attendees to interact with the faculty about their experiences managing patients with T2DM.

 

EXPERT INSIGHTS ON USE OF NEW AND EMERGING MINIMALLY INVASIVE TECHNIQUES FOR OPTIMAL FACIAL REJUVENATION

This initiative reviews the anatomy and physiology of aging skin/tissue as it relates to facial rejuvenation and the evolution of minimally invasive aesthetic techniques. It also includes the most current information on an emerging option - absorbable lifting sutures - and use of combination therapy to individualize treatment plans and facilitate optimal patient outcomes. Live and/or video patient treatment demonstrations provide step-by-step instruction and insight into the latest advances in facial rejuvenation.

This activity expired for credit on May 16, 2017

 

CONFRONTING CHALLENGES IN PLAQUE PSORIASIS MANAGEMENT: CHOICES, CONTROVERSIES, AND CASE STUDIES

Psoriasis is a disorder that requires optimal care by clinicians who understand how to treat patients as individuals based on their personal and disease characteristics, as well as the nuances of available agents. This webinar features dermatology experts describing how to tailor psoriasis therapy based on pathophysiology, disease symptoms, and patient goals; illustrating the incorporation of newly approved biologic agents for moderate and severe disease. The faculty discussion of the interactive polling questions and cases provides practical clinical insights on management of psoriasis.

 

APPLYING GUIDELINE RECOMMENDED AND RECENT EVIDENCE-BASED THERAPIES IN THE TREATMENT OF CHRONIC HEART FAILURE

As the US population ages, more patients are being diagnosed with chronic heart failure (HF). There are established standard-of-care medications, but use of them has been shown to be suboptimal. In the last year, novel therapies have become available, but many clinicians are unclear on their role in the management of chronic HF. In addition, many clinicians want a greater understanding of the underlying pathophysiology of chronic HF. The live symposium and online monograph "Applying Guideline-Recommended and Recent Evidence-Based Therapies in the Treatment of Chronic Heart Failure" will arm cardiologists, primary care providers, hospitalists, emergency medicine specialists, and other clinicians with the information they need to effectively manage chronic HF in a range of patients. The expert faculty will describe the pathophysiology of chronic HF, differentiating between HF with reduced or preserved left ventricular ejection fraction. The faculty will review the most recent updates to evidence-based treatment guidelines, focusing on recommendations for pharmacologic management, and will describe the mechanisms of action of, clinical evidence for, and appropriate use of newer chronic HF therapies.

This activity expires for credit on April 19, 2018

 

DELVING DEEPER INTO THE COMPLEXITIES AND PERPLEXITIES OF ORAL ANTICOAGULATION

You've reached the decision to move away from warfarin and prescribe a novel oral anticoagulant (NOAC) for your patient, to reduce the risk of stroke in nonvalvular atrial fibrillation or to prevent or treat venous thromboembolism. But next steps can be daunting: With which 1 of 4 available NOACs do you individualize therapy? At what dosage? Will age, renal function, or concomitant medications factor into your strategy? And what protocols and agents do you employ when it's necessary to reverse anticoagulation in a patient taking a NOAC who is bleeding or requires surgery? Through challenging case reviews, three experts from Harvard's Brigham and Women's Hospital answer these and other questions about providing safe and efficacious use of NOACs.

This activity expires for credit on January 26, 2018

 

COMBATING MULTIDRUG-RESISTANT ORGANISMS: STRATEGIC CONSIDERATIONS FOR OPTIMAL CLINICAL OUTCOMES

After a long dry spell, the antibiotic pipeline is showing signs of resurgence. To withstand resistance in the coming years, infectious disease clinicians will be called on to optimize the use of new agents, and to lead antimicrobial stewardship efforts, which have become urgent professional and government priorities. Doing so will require a thorough understanding of multidrug-resistant pathogens, their mechanisms of resistance, and the role and function of new antibiotics in surmounting the growing problem of resistant infections. Our distinguished panel of infectious disease experts will address these critical issues in an engaging, interactive, case-based, format.

 

DIAGNOSING AND MANAGING IRRITABLE BOWEL SYNDROME IN FAMILY PRACTICE: THE LATEST NEWS AND PATIENT VIEWS

The personalized care and therapeutic relationship required for optimal IBS management resides firmly within the purview of family practitioners (FPs), who are known for their care and concern for the whole patient. This program was designed to increase FP awareness of updated diagnostic criteria, new diagnostic tools, and new treatment paradigms through the use of case-based scenarios, and to translate specialist-focused recommendations into family practice, fostering better care of patients with IBS, who often feel frustrated and unheard during clinical encounters.

This activity expired for credit on September 22, 2016


ADVANCING THE CARE OF POST-ACNE SCARRING: EXPERT INSIGHTS INTO NEW TREATMENT OPTIONS

Optimal management of patients with atrophic facial scars of acne vulgaris requires mindfulness of the patient's psychosocial burden; familiarity with the latest evidence-based data on efficacy and safety of available treatment modalities; and the ability to match a patient's skin type, unique scar formation, and desired outcomes with the most appropriate treatment. During this CME-accredited activity, a panel of experts will address barriers to optimal treatment through presentations integrating didactic content with video case studies that include relevant demonstrations of patient assessment and treatment.

This activity expired for credit on May 11, 2017

 

THE EVOLVING ROLE OF ORAL ANTICOAGULATION IN INTERNAL MEDICINE: NVAF, DVT, AND PE BEST PRACTICES

Internal medicine clinicians (IMs) are on the frontlines of managing patients who are eligible for direct oral anticoagulant (DOAC) therapy, including those with nonvalvular atrial fibrillation (NVAF) who are at risk for stroke, and those with venous thromboembolism, including deep vein thrombosis (DVT) and/or pulmonary embolism (PE), who may be at risk for recurrence. This educational initiative, "The Evolving Role of Oral Anticoagulation in Internal Medicine: NVAF, DVT, and PE Best Practices," provides expert-led, evidence-based guidance on the practical, safe, and effective use of DOACs for the optimal treatment of eligible patients in internal medicine. This case-based education will help IMs tailor DOAC use to a variety of clinical scenarios, including special patient populations (eg, elderly or renally impaired patients), while contemplating a broad range of important considerations related to the indications, contraindications, dosing, and pharmacology of the individual agents. It will also address the management of DOACs in the presence of common clinical challenges such as bleeding or the need for surgery.

This activity expires for credit on July 6, 2017

 

"DETECT AND PROTECT" AGAINST MULTIDRUG-RESISTANT ORGANISMS: STRATEGIC AND RESPONSIBLE USE OF NEW ANTIBIOTICS

Healthcare-related bacterial infections caused by multidrug-resistant organisms (MDROs) are on the rise, putting hospital-based ID specialists on high alert. Newer antibiotic agents are available or soon will be, but many clinicians are unclear on which types of infections will respond to which agents or are unaware that some of these medications exist. This continuing education activity will give clinical pharmacists, ID specialists, and other interested ID healthcare team members the information they need to battle healthcare-related infections. The expert faculty will describe strategies for treating Gram-positive and Gram-negative infections, review the indications and data on new and investigational antibiotics, and discuss key principles of antimicrobial stewardship and how to apply them to clinical practice.

This activity expired for credit on October 6, 2015

 

ADVANCING THE TREATMENT STRATEGIES IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: THE UROLOGIST'S ROLE

This text-based, interactive, CME-certified web monograph features audio and video clips of expert faculty interviews and discussions and was designed to provide urologists, medical and radiation oncologists, and other healthcare professionals with the latest information on monitoring parameters that may help guide treatment decisions or indicate efficacy of therapy. The faculty also provide information on differences among available therapies to facilitate evidence-based, individualized treatment decisions and the roles of multidisciplinary team members in managing mCRPC patients.

This activity expired for credit on August 3, 2016

 

TYPE 2 DIABETES MANAGEMENT: CURRENT GUIDELINES AND DECIPHERING THE LATEST THERAPY OPTIONS.

An individualized approach to management of type 2 diabetes mellitus (T2DM) may be the most likely tactic for achieving the best outcomes for any given T2DM patient, but it poses a challenge to clinicians with limited time and resources, especially given the ever-expanding armamentarium of antidiabetic drugs - including the incretin-based classes (GLP-1 receptor agonists and DPP-4 inhibitors), SGLT2 inhibitors, and combination agents. This CME-certified web monograph, which includes faculty audio clips and interactive questions, was designed to help guide appropriate treatment selection based on the T2DM patient's clinical characteristics, therapeutic goals, and patient's preference.

This activity expired for credit on August 13, 2016

 

ADVANCES IN IMMUNOTHERAPY FOR ADVANCED MELANOMA: INTEGRATING INTRALESIONAL AND ANTI-PD-1 IMMUNOTHERAPIES INTO CURRENT PRACTICE

This CME-certified satellite symposium at the Society of Surgical Oncology (SSO) 2015 Annual Meeting included didactic presentations, interactive case presentations, and a moderated Q&A discussion with the faculty panel. Throughout the symposium, attendees used iPads to view the program, take notes, interact with faculty, and complete the posttest, increasing audience interaction. An enduring audio webinar based upon the proceedings of the live symposium is hosted on www.paradigmmc.com.

This activity expired for credit on May 22, 2016

 

OUT WITH THE OLD? IN WITH THE NEW? BAD BUGS, NEW DRUGS, AND ANTIMICROBIAL STEWARDSHIP

This live, interactive CME satellite symposium, presented at IDWeek™ 2014, included didactic lectures and in-depth moderated Q&A between attendees and faculty focusing on optimal treatment strategies for the management of hospital-acquired infections frequently associated with MDROs and new and emerging treatment aligned with the tenets of antimicrobial stewardship. The enduring web monograph, developed from the proceedings of the live symposium, was hosted on the Paradigm website, www.paradigmmc.com, and distributed via Paradigm and Elsevier on the MEDLINE-indexed American Journal of Infection Control website, as well as other appropriate web portals.

This activity expired for credit on January 19, 2016

 

BREAKTHROUGHS IN UNDERSTANDING AND TREATING CHRONIC IDIOPATHIC CONSTIPATION AND IRRITABLE BOWEL SYNDROME

This live, interactive CME-certified satellite symposium included didactic lectures and in-depth moderated faculty discussions and Q&A between attendees and faculty. It was presented at ACG 2014. The enduring web monograph was developed from the proceedings of the live symposium, and is accessible via the Paradigm website, www.paradigmmc.com, as well as Paradigm's gastroenterology-focused portal.

This activity expired for credit on January 28, 2016.

 

TYPE 2 DIABETES TREATMENT FOR DIVERSE POPULATIONS: INTEGRATING NEW AND EMERGING AGENTS

This live CME symposium, held in conjunction with the American Diabetes Association 74th Scientific Sessions 2014, was developed for healthcare professionals actively involved in the management of patients with diabetes. The dynamic faculty discussion focused on the consequences of inadequate diabetes management as well as characteristics of the incretin-based therapies and SGLT2 inhibitors, including their extraglycemic effects. The enduring on-demand CME/CE webinar further advanced the educational impact and reach of the program.

This activity expired for credit on July 10, 2015

 

UNRAVELING MYTHS AND MISCONCEPTIONS ABOUT IBS-C AND CHRONIC CONSTIPATION IN FAMILY PRACTICE

This live, interactive satellite symposium presented at the AAFP's 2014 Scientific Assembly incorporated ARS technology with didactic lectures, challenging real-world clinical cases, roundtable discussions, and a question and answer session. The enduring, web-based monograph was developed from the proceedings of the live symposium.

This activity expired for credit on October 23, 2014

 

MANAGING CHRONIC CONSTIPATION AND IBS WITH CONSTIPATION: NEW EVIDENCE OF OVERLAP, DISTINCTIONS, AND IMPROVED TREATMENT STRATEGIES

This live, interactive CME/CE satellite symposium at the Digestive Disease Week 2014 discussed the incidence, impact, and patient management strategies for CC and IBS-C for GI specialists, including differential diagnosis, review of evidence-based guidelines, current therapeutic options, and appropriate use of novel and emerging treatments. An enduring, interactive web monograph was developed from the proceedings of the live symposium to extend the reach to clinicians unable to attend the meeting.

This activity expired for credit on July 25, 2015

 

ADDRESSING THE CHALLENGES OF IBS AND CHRONIC IDIOPATHIC CONSTIPATION

This live, interactive CME satellite symposium at the ACP's Internal Medicine 2014 was designed to educate internal medicine specialists on how to correctly characterize and diagnose IBS subtype(s) and chronic idiopathic constipation and appropriately use new and emerging agents that address underlying pathophysiology and target global symptoms. An enduring, interactive CME/CE web monograph was based upon the proceedings of the live symposium, and featured key points of the presentation and faculty discussion.

This activity expired for credit on July 11, 2015

 

COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: THE EMERGENCY DEPARTMENT AS A PIVOTAL ROLE POINT OF CARE

This live, CME-certified, case-based, interactive satellite symposium was presented at the 2013 ACEP Scientific Assembly. The on-demand MEDLINE-indexed web monograph featured an interactive text version of the faculty presentations and cases from the live meeting, and was hosted and distributed on the Paradigm website, www.paradigmmc.com and www.annemergmed.com, the website of the Annals of Emergency Medicine. The web activity was also distributed by Elsevier via email blasts and via print and banner ads to their emergency medicine and critical care journal subscribers.

This activity expired for credit on December 17, 2014

 

ABSSSI AND CABP: MAXIMIZING THE ANTI-INFECTIVE ARSENAL TO OPTIMIZE PATIENT OUTCOMES

This live, CME-certified satellite symposium was presented at IDWeek 2013. It included didactic lecture, panel discussion, and interactive cases. An interactive, on-demand MEDLINE-indexed web monograph featuring highlights of faculty presentations and cases from the live symposium was hosted and distributed on the Paradigm website, www.paradigmmc.com, and id.theclinics.com, and distributed by Elsevier via email blasts and print and banner ads in their infectious disease, emergency medicine, and internal medicine journals.

This activity expired for credit on October 2, 2013

 

IRRITABLE BOWEL SYNDROME AND CHRONIC CONSTIPATION: DIGESTING RECENT ADVANCES AND CURRENT THINKING

This live, CME-certified, didactic and case-based moderator-led interactive satellite symposium at ACG Annual Scientific Meeting 2013, was also streamed as a live webcast, marketed to over 14,400 GI specialists. An on-demand enduring webinar was developed based on the live symposium and was hosted on Paradigm's website (www.paradigmmc.com) and the CECity website (www.cecity.com).

This activity expired for credit on December 2, 2014

 

DIABETES AND CARDIOVASCULAR DISEASE: THE WELL-ESTABLISHED CONNECTION A DEBATE AMONG EXPERTS

This live CME symposium, held in conjunction with the American Heart Association Scientific Sessions 2013, consisted of a dynamic discussion structured around didactic lectures and challenging real-world patient cases. The enduring on-demand webinar further advanced the educational impact and reach of the program. The initiative was designed to educate clinicians involved in the management of patients with diabetes on how to improve care by communicating the latest significant, comprehensive, evidence-based advances in the diagnosis and treatment of diabetes and to address the more important issue of diabetes with comorbid conditions such as CVD.

This activity expired for credit on January 14, 2015

 

A MEN'S HEALTH INITIATIVE: FOCUS ON MALE HYPOGONADISM AND TESTOSTERONE REPLACEMENT THERAPY

This enduring, CME-certified web monograph was branded by Urology ("The Gold Journal") and hosted on www.goldjournal.net. The web monograph was MEDLINE-indexed and distributed by Elsevier via email blasts, print and banner ads to their mix of Urology and Internal Medicine Journals. The webinar was followed by a live CME-certified satellite symposium, held in conjunction with the Southeast Section meeting of the AUA in March 2014.

This activity expired for credit on November 7, 2014

 

COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: INPATIENT STRATEGY FOR HOSPITALISTS

This live, CME-certified, case-based, interactive satellite symposium at the SHM's 2013 Annual Meeting included challenging real-world clinical cases interspersed with didactic lectures and audience participation technology. The enduring, on-demand web activity, featuring an interactive text-based format of faculty presentations and discussions, was based on the proceedings of the live symposium. The enduring activity was hosted on The Hospitalist's website, www.the-hospitalist.org (an official website of the SHM), and cross-linked to www.paradigmmc.com.

This activity expired for credit on September 10, 2014

 

HARNESSING THE POWER OF INTRALESIONAL THERAPY FOR UNRESECTABLE MELANOMA

This live, interactive symposium, comprising didactic lectures, challenging real-world clinical cases, and a question-and-answer session with the faculty panel, was held as an ancillary symposium at the 2013 ASCO Annual Meeting and Exhibition. The enduring, on-demand web activity was based on the proceedings of the live symposium, hosted on www.realcme.com, and distributed via the Epocrates/MDLinx mobile and online networks. A link was also placed on Paradigm's website, www.paradigmmc.com, and the activity was promoted to Paradigm's internal database of oncology professionals.

This activity expired for credit on September 5, 2014

 

THE ROLE OF THE CLINICAL PHARMACIST AS A CATALYST FOR APPROPRIATE ANTIBIOTIC DECISION-MAKING IN 2012 AND BEYOND: FOCUS ON CABP AND ABSSSI

This live, case-enhanced, audience-interactive CME satellite symposium at the ACCP 2012 Annual Meeting was targeted to clinical pharmacists. An enduring, case-enhanced, interactive web monograph, developed based on the live symposium, was hosted and distributed by Power-Pak C.E.

This activity expired for credit on January 27, 2014

 

THE INFECTIOUS DISEASE SPECIALIST AS THE CATALYST FOR INFORMED ANTI-INFECTIVE DECISION MAKING IN THE HOSPITAL SETTING: FOCUS ON CABP AND ABSSSI

This live, interactive, case-based CME symposium following the Official Programming of the 49th Annual Meeting of the IDSA was videotaped and then developed into an interactive on-demand webinar hosted on Paradigm's website. Both activities presented vital information on the optimal management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in the hospital setting, with particular attention to the role of new anti-infective agents.

This activity expired for credit on January 5, 2014

 

ROLE OF THE CLINICAL PHARMACIST AS A CATALYST FOR APPROPRIATE ANTIBIOTIC DECISION MAKING

Targeting health-system pharmacists, this CPE satellite symposium conducted at the 46th ASHP Midyear Clinical Meeting and Exhibition, used a combination of didactic lectures, interactive case studies, and panel discussion to enhance participants' understanding of evidence-based management community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections as well as the critical role of clinical pharmacists in educating other healthcare professionals, establishing evidence-based clinical pathways, and setting standards for optimal patient care and medication use for these serious infections.

This activity expired for credit on December 5, 2011

 

ADVANCES IN PSORIASIS: A CASE-BASED EXCHANGE FOCUSED ON TREATMENT CHALLENGES IN MODERATE TO SEVERE PSORIASIS

Dermatologists, along with PAs and NPs who specialize in dermatology, are at the forefront of managing psoriasis, which is estimated to affect up to 7.4 million adults in the United States. During this series of 3 live meetings, expert faculty will describe the characteristics of different severity levels of psoriasis, review appropriate treatment selection for moderate to severe psoriasis based on characteristics of available therapies and patient characteristics, and discuss effective strategies to address barriers to treatment adherence among patients with psoriasis, with the goal of improving patient outcomes.

This activity expired for credit on May 12, 2011

 

CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD): BETTER BREATHING BEGINS IN INTERNAL MEDICINE

Many clinicians are not aware of or do not apply evidence based guideline recommendations to identify COPD patients early and accurately. Clinicians face challenges when selecting appropriate maintenance therapy and often don't ensure adherence to inhaled COPD medications. This live, interactive CME-certified satellite symposium held at Internal Medicine 2016 and text-based, CME-certified web monograph, featuring audio and video clips of faculty interviews, discussions, and therapeutic device administration demonstration will help internists better apply recommended diagnostic tools, develop appropriate individualized maintenance treatment and recognize strategies to improve adherence to COPD maintenance therapy.

 

MANAGING ADVANCED BLADDER CANCER: THE UROLOGIST'S PERSPECTIVE

During this interactive and engaging symposium, experts in the field will provide the most recent evidence regarding selection of patients with advanced bladder cancer for neoadjuvant chemotherapy, as well as address concerns surrounding chemotherapy before surgery. In addition, current data on emerging immune checkpoint inhibitors, including potential future applications in the neoadjuvant and adjuvant setting, will be presented. Strategies for implementing multidisciplinary approaches and shared decision making in clinical practice will also be provided.

 

UNCOVERING THE NUANCES OF ORAL ANTICOAGULATION FOR OPTIMAL MANAGEMENT OF HOSPITALIZED PATIENTS

During this CME-certified symposium, expert faculty will provide guidance - via didactic lecture and interactive case studies - on how to identify at-risk patients who are candidates for oral anticoagulation therapy in the hospital setting. Through the use of iPad technology to enhance the learning experience, participants will be provided with evidenced-based information allowing for differentiating among the oral anticoagulants, selecting the most appropriate oral anticoagulant for at-risk patients based on individual drug and patient characteristics; and understanding strategies for stopping and reinitiating anticoagulation in patients undergoing surgical procedures.

This activity expired for credit on April 6, 2017

 

NONWARFARIN ORAL ANTICOAGULANTS (NOACS): THE CLINICAL PHARMACIST'S PERSPECTIVE

Few topics are as relevant - or of as intense interest - to contemporary pharmacy practice as the appropriate use of nonwarfarin oral anticoagulants (NOACs) approved by the FDA in January 2015. NOACs offer distinct advantages over warfarin; they have a rapid onset of action, more predictable pharmacologic profiles, and significantly reduced food and drug interactions. This activity offers education for clinical pharmacists on the latest evidence surrounding the different indications for NOACs, proper dosing strategies, management of bleeding, counseling patients on the safe use of NOACs (and how they differ from warfarin), managing and monitoring for food-drug and drug-drug interactions, and managing care transitions.

This activity expired for credit on March 18, 2017

 

CONSIDERATIONS IN THE CLINICAL USE OF NON-WARFARIN ORAL ANTICOAGULATION IN THROMBOSIS

Nonwarfarin oral anticoagulants (NOACs) have emerged as key therapies to prevent and/or treat potentially deadly thrombotic conditions including stroke or systemic embolic events in patients with nonvalvular atrial fibrillation and venous thromboembolism. Although NOACs offer many advantages over conventional therapies, confusion over certain aspects of their safe and effective use in clinical practice persist. This educational activity will provide the latest data and recommendations in a case-based format to help guide the appropriate and confident use of NOACs in a variety of scenarios commonly encountered in clinical practice.

This activity expired for credit on November 9, 2015

 

ANTICOAGULATION IN THE EMERGENCY DEPARTMENT: A CASE-BASED APPROACH TO MANAGING PATIENTS WITH VENOUS THROMBOEMBOLISM AND NONVALVULAR ATRIAL FIBRILLATION

This live, interactive continuing medical education program will review current evidence and strategies for applying the information to confidently make appropriate "real-time" patient-centered treatment decisions in the emergency department with regard to the use of oral anticoagulation, and in particular the nonwarfarin oral anticoagulants. Key information will be presented in the context of patient case scenarios with the opportunity for participants to have their questions addressed by faculty. Topics include red flags for recognition and efficient diagnosis of nonvalvular atrial fibrillation and venous thromboembolism in the emergency department, balanced risk assessment for thrombosis and bleeding, choosing among available oral anticoagulants, and new strategies for managing acute bleeding events.

This activity expired for credit on February 26, 2017

 

CLINICAL PHARMACISTS AND CHRONIC HEART FAILURE: UNDERSTANDING THE ROLE OF NEW AND ESTABLISHED THERAPIES

This initiative will define chronic heart failure (CHF) with reduced ejection fraction (HFrEF or systolic HF) and will provide visual information and expert instruction to help clinical pharmacists differentiate between CHF/HFrEF and CHF with preserved ejection fraction (HFpEF, or diastolic heart failure). Faculty will review existing algorithms for the use of established cardiovascular drugs in treating CHF/HFrEF and describe the mechanisms of action, approved or proposed indications, and role of new and emerging agents in the treatment of CHF/HFrEF. The information presented will be vital to clinical pharmacists who are assuming an ever increasing role on the CHF treatment team.

This activity expired for credit on February 24, 2017

 

OPTIMAL ANTICOAGULATION THERAPY: A PRESCRIPTION FOR IMPROVEMENT

Atrial fibrillation (AF) and venous thromboembolism (VTE) are among the most common and serious thromboembolic conditions seen in clinical practice. Despite the pharmacokinetic and pharmacodynamic advantages of the nonwarfarin oral anticoagulants over warfarin and their similar or better efficacy to reduce the risk of stroke in patients with nonvalvular AF and for recurrent VTE while reducing the risk for serious bleeding, these agents are still not appropriately used. In this CPE initiative, which includes a didactic lecture combined with a clinical case or cases pertinent to the role of the clinical pharmacist as a critical member of the anticoagulation management team, clinical pharmacy-driven strategies to improve processes of care and anticoagulation management (eg, integration of guidelines into clinical practice) are described.

This activity expired for credit in July 2015

 

ADVANCES IN PSORIASIS: A CASE-BASED EXCHANGE FOCUSED ON TREATMENT CHALLENGES IN MODERATE TO SEVERE PSORIASIS

Dermatologists, along with PAs and NPs who specialize in dermatology, are at the forefront of managing psoriasis, which is estimated to affect up to 7.4 million adults in the United States. During this series of 3 live meetings, expert faculty will describe the characteristics of different severity levels of psoriasis, review appropriate treatment selection for moderate to severe psoriasis based on characteristics of available therapies and patient characteristics, and discuss effective strategies to address barriers to treatment adherence among patients with psoriasis, with the goal of improving patient outcomes.

This activity expired for credit on February 2, 2017

 

RECENT ADVANCES AND EMERGING TRENDS IN ONYCHOMYCOSIS MANAGEMENT: A SERIES OF LIVE CME SATELLITE SYMPOSIA AND AN ENDURING ON-DEMAND WEBINAR

Onychomycosis - a chronic infectious disease with significant medical and psychosocial consequences - can be extremely challenging to eradicate. To manage onychomycosis effectively, clinicians need to understand the etiology, diagnosis, and management of onychomycosis as a chronic infectious disease. They must also understand the characteristics of current topical, systemic, and mechanical treatments and be able to appropriately integrate new and emerging therapies into their practice based on treatment benefits and risks and patient factors. This initiative was designed to educate dermatologic clinicians on recent advances and emerging trends in onychomycosis management based on evidence from clinical trials, data on newer antifungal agents, and expert opinion and recommendations.

This activity expired for credit on February 23, 2017

 

ADVANCES IN ATOPIC DERMATITIS: EXPERT INSIGHTS INTO NEW AND EMERGING THERAPIES

Atopic dermatitis (AD) is a chronic, inflammatory, relapsing disorder that can result from a number of different factors including genetics, immune system dysfunction, and possibly environmental exposures. Because there is no known cure, treating patients with AD can be challenging and often frustrating for both the clinician and the patient. This CME provides information on the role of immune abnormalities and skin-barrier dysfunction in the development of AD and how this understanding informs and can help guide treatment selection. Expert faculty will discuss the 2014 AAD guidelines and other recent guidelines for diagnosis and management of AD, and summarize data on current and emerging topical and systemic therapies to help providers optimize treatment outcomes.

This activity expired for credit on November 30, 2016

 

PRACTICAL TRAINING IN FACIAL AESTHETICS: A COMPREHENSIVE MEDICAL EDUCATION INITIATIVE ON INJECTABLES

This CME/CE-certified initiative was designed to provide physicians, nurse practitioners, and medical residents/fellows with comprehensive training on the spectrum of noninvasive injectables used in facial aesthetic therapy.


DUAL ORAL ANTIPLATELET THERAPY FOR ACS: IMPROVING STANDARDS OF CARE TO OPTIMIZE OUTCOMES

This live CME-certified symposium at the AHA Scientific Sessions 2014 was designed for cardiologists and interventional cardiologists, primary care physicians, hospitalists, fellows, PAs, NPs, and other healthcare providers caring for patients with ACS. It reviewed the latest guidelines for dual oral antiplatelet therapy for patients presenting with ACS and described recent data on these therapies in patients with UA/NSTEMI and STEMI.

Based on the live presentation, the CME/CE-certified enduring webinar is intended for cardiologists, interventional cardiologists, emergency department physicians, primary care physicians, hospitalists, fellows, PAs, NPs, and other healthcare professionals caring for or interested in the management of patients with ACS.

This activity concluded on July 1, 2014

 

DIABETES AND CARDIOVASCULAR DISEASE: THE WELL-ESTABLISHED CONNECTION A DEBATE AMONG EXPERTS

This live CME symposium, held in conjunction with the American Heart Association Scientific Sessions 2013, consisted of a dynamic discussion structured around didactic lectures and challenging real-world patient cases. The enduring on-demand webinar further advanced the educational impact and reach of the program. The initiative was designed to educate clinicians involved in the management of patients with diabetes on how to improve care by communicating the latest significant, comprehensive, evidence-based advances in the diagnosis and treatment of diabetes and to address the more important issue of diabetes with comorbid conditions such as CVD.

This activity expired for credit on January 14, 2015

 

TYPE 2 DIABETES TREATMENT FOR DIVERSE POPULATIONS: INTEGRATING NEW AND EMERGING AGENTS

This live CME symposium, held in conjunction with the American Diabetes Association 74th Scientific Sessions 2014, was developed for healthcare professionals actively involved in the management of patients with diabetes. The dynamic faculty discussion focused on the consequences of inadequate diabetes management as well as characteristics of the incretin-based therapies and SGLT2 inhibitors, including their extraglycemic effects. The enduring on-demand CME/CE webinar further advanced the educational impact and reach of the program.

This activity expired for credit on July 10, 2015

 

UPDATE ON FEBRILE NEUTROPENIA PROPHYLAXIS: EXPERT PERSPECTIVES ON APPROPRIATE USE AND COST-EFFECTIVE CHOICES

This live, interactive CPE-certified satellite symposium, held at the American Society of Health-System Pharmacists' 2014 Summer Meeting and Exhibition, included didactic lectures and real-world cases covering guideline-concordant uses of G-CSF agents available for febrile neutropenia prophylaxis, based on identification of risk factors as well as strategies for minimizing the high cost burden associated with this condition. The enduring web monograph complemented and extended the educational impact and reach of the program.

This activity expired for credit on August 18, 2015

 

ADDRESSING THE CHALLENGES OF IBS AND CHRONIC IDIOPATHIC CONSTIPATION

This live, interactive CME satellite symposium at the ACP's Internal Medicine 2014 was designed to educate internal medicine specialists on how to correctly characterize and diagnose IBS subtype(s) and chronic idiopathic constipation and appropriately use new and emerging agents that address underlying pathophysiology and target global symptoms. An enduring, interactive CME/CE web monograph was based upon the proceedings of the live symposium, and featured key points of the presentation and faculty discussion.

This activity expired for credit on July 11, 2015

 

MANAGING CHRONIC CONSTIPATION AND IBS WITH CONSTIPATION: NEW EVIDENCE OF OVERLAP, DISTINCTIONS, AND IMPROVED TREATMENT STRATEGIES

This live, interactive CME/CE satellite symposium at the Digestive Disease Week 2014 discussed the incidence, impact, and patient management strategies for CC and IBS-C for GI specialists, including differential diagnosis, review of evidence-based guidelines, current therapeutic options, and appropriate use of novel and emerging treatments. An enduring, interactive web monograph was developed from the proceedings of the live symposium to extend the reach to clinicians unable to attend the meeting.

This activity expired for credit on July 25, 2015

 

UNRAVELING MYTHS AND MISCONCEPTIONS ABOUT IBS-C AND CHRONIC CONSTIPATION IN FAMILY PRACTICE

This live, interactive satellite symposium presented at the AAFP's 2014 Scientific Assembly incorporated ARS technology with didactic lectures, challenging real-world clinical cases, roundtable discussions, and a question and answer session. The enduring, web-based monograph was developed from the proceedings of the live symposium.

This activity expired for credit on October 23, 2014

 

BREAKTHROUGHS IN UNDERSTANDING AND TREATING CHRONIC IDIOPATHIC CONSTIPATION AND IRRITABLE BOWEL SYNDROME

This live, interactive CME-certified satellite symposium included didactic lectures and in-depth moderated faculty discussions and Q&A between attendees and faculty. It was presented at ACG 2014. The enduring web monograph was developed from the proceedings of the live symposium, and is accessible via the Paradigm website, www.paradigmmc.com, as well as Paradigm's gastroenterology-focused portal.

This activity expired for credit on January 28, 2016.

 

IRRITABLE BOWEL SYNDROME AND CHRONIC CONSTIPATION: DIGESTING RECENT ADVANCES AND CURRENT THINKING

This live, CME-certified, didactic and case-based moderator-led interactive satellite symposium at ACG Annual Scientific Meeting 2013, was also streamed as a live webcast, marketed to over 14,400 GI specialists. An on-demand enduring webinar was developed based on the live symposium and was hosted on Paradigm's website (www.paradigmmc.com) and the CECity website (www.cecity.com).

This activity expired for credit on December 2, 2014

 

REASSESSING THE ROLE OF β-BLOCKERS IN THE MANAGEMENT OF HYPERTENSION

This live, interactive CME-certified satellite symposium presented at the ACP's Internal Medicine 2014 included didactic lectures, challenging real-world clinical cases, and a question-and-answer session with the faculty panel. The interactive CME/CE-certified enduring web monograph was hosted on the Paradigm website, www.paradigmmc.com, and distributed via several mechanisms, including an aggressive, multifaceted promotional campaign to physicians and healthcare professionals in Paradigm's learner database and PeerAudience's OpenCME Network.

This activity expired for credit on April 8, 2014

 

HYPONATREMIA: ADDRESSING THE PATHOPHYSIOLOGIC CAUSES AND THEIR CONSEQUENCES

This CME initiative consisted of live grand rounds meetings at hospitals across the country, providing hospital-based physicians and other clinicians involved in the management of hyponatremia with a systematic approach to diagnosing, assessing, and selecting appropriate treatment options for hyponatremia based on underlying pathophysiology and symptom severity. Each activity was conducted by an expert in the field of hyponatremia and included a didactic lecture, a review of relevant case studies, and a discussion session with participants.

This activity expired for credit on August 21, 2012

 

RESTORING THE BALANCE: HOSPITALIST'S ROLE IN MANAGING HYPONATREMIA

This live, interactive CME-certified symposium was held in conjunction with Hospital Medicine 2012, the Society of Hospital Medicine's Annual Meeting. This case-based initiative also included an interactive on-demand webinar in collaboration with www.the-hospitalist.org and a mobile application to help clinicians better recognize and manage hyponatremia.

This activity expired for credit on April 3, 2012

 

MANAGEMENT OF HYPONATREMIA: PHARMACY'S KEY ROLE

This CPE satellite symposium was held during the American College of Clinical Pharmacy's 2010 Annual Meeting. Designed for pharmacists interested in the management of hyponatremia, and cosponsored by the University of North Carolina Eshelman School of Pharmacy, this symposium highlighted the importance of proper management of this common electrolyte disorder. A print supplement to the journal Pharmacotherapy included the highlights of this important meeting.

 

ADVANCES IN PSORIASIS: A CASE-BASED EXCHANGE FOCUSED ON TREATMENT CHALLENGES IN MODERATE TO SEVERE PSORIASIS

Dermatologists, along with PAs and NPs who specialize in dermatology, are at the forefront of managing psoriasis, which is estimated to affect up to 7.4 million adults in the United States. During this series of 3 live meetings, expert faculty will describe the characteristics of different severity levels of psoriasis, review appropriate treatment selection for moderate to severe psoriasis based on characteristics of available therapies and patient characteristics, and discuss effective strategies to address barriers to treatment adherence among patients with psoriasis, with the goal of improving patient outcomes.

This activity expired for credit on May 12, 2011

 

A CASE-BASED APPROACH TO THE EFFECTIVE MANAGEMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS: STRATEGIES FOR APPROPRIATE MANAGEMENT TO ENSURE OPTIMAL PATIENT OUTCOMES

This live and enduring CME initiative was designed to help hospitalists take a leadership role to ensure rapid recognition and appropriate treatment of C difficile infections and allow them to implement effective strategies for prevention. The initiative included a live satellite symposium in conjunction with Hospital Medicine 2011-SHM Annual Meeting and featured a MEDLINE-indexed print supplement to the Journal of Hospital Medicine.

This activity expired for credit on May 12, 2011

 

ROLE OF THE CLINICAL PHARMACIST AS A CATALYST FOR APPROPRIATE ANTIBIOTIC DECISION MAKING

Targeting health-system pharmacists, this CPE satellite symposium conducted at the 46th ASHP Midyear Clinical Meeting and Exhibition, used a combination of didactic lectures, interactive case studies, and panel discussion to enhance participants' understanding of evidence-based management community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections as well as the critical role of clinical pharmacists in educating other healthcare professionals, establishing evidence-based clinical pathways, and setting standards for optimal patient care and medication use for these serious infections.

This activity expired for credit on December 5, 2011

 

THE INFECTIOUS DISEASE SPECIALIST AS THE CATALYST FOR INFORMED ANTI-INFECTIVE DECISION MAKING IN THE HOSPITAL SETTING: FOCUS ON CABP AND ABSSSI

This live, interactive, case-based CME symposium following the Official Programming of the 49th Annual Meeting of the IDSA was videotaped and then developed into an interactive on-demand webinar hosted on Paradigm's website. Both activities presented vital information on the optimal management of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections in the hospital setting, with particular attention to the role of new anti-infective agents.

This activity expired for credit on January 5, 2014

 

THE ROLE OF THE CLINICAL PHARMACIST AS A CATALYST FOR APPROPRIATE ANTIBIOTIC DECISION-MAKING IN 2012 AND BEYOND: FOCUS ON CABP AND ABSSSI

This live, case-enhanced, audience-interactive CME satellite symposium at the ACCP 2012 Annual Meeting was targeted to clinical pharmacists. An enduring, case-enhanced, interactive web monograph, developed based on the live symposium, was hosted and distributed by Power-Pak C.E.

This activity expired for credit on January 27, 2014

 

COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: INPATIENT STRATEGY FOR HOSPITALISTS

This live, CME-certified, case-based, interactive satellite symposium at the SHM's 2013 Annual Meeting included challenging real-world clinical cases interspersed with didactic lectures and audience participation technology. The enduring, on-demand web activity, featuring an interactive text-based format of faculty presentations and discussions, was based on the proceedings of the live symposium. The enduring activity was hosted on The Hospitalist's website, www.the-hospitalist.org (an official website of the SHM), and cross-linked to www.paradigmmc.com.

This activity expired for credit on September 10, 2014

 

ABSSSI AND CABP: MAXIMIZING THE ANTI-INFECTIVE ARSENAL TO OPTIMIZE PATIENT OUTCOMES

This live, CME-certified satellite symposium was presented at IDWeek 2013. It included didactic lecture, panel discussion, and interactive cases. An interactive, on-demand MEDLINE-indexed web monograph featuring highlights of faculty presentations and cases from the live symposium was hosted and distributed on the Paradigm website, www.paradigmmc.com, and id.theclinics.com, and distributed by Elsevier via email blasts and print and banner ads in their infectious disease, emergency medicine, and internal medicine journals.

This activity expired for credit on October 2, 2013

 

COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA: THE EMERGENCY DEPARTMENT AS A PIVOTAL ROLE POINT OF CARE

This live, CME-certified, case-based, interactive satellite symposium was presented at the 2013 ACEP Scientific Assembly. The on-demand MEDLINE-indexed web monograph featured an interactive text version of the faculty presentations and cases from the live meeting, and was hosted and distributed on the Paradigm website, www.paradigmmc.com and www.annemergmed.com, the website of the Annals of Emergency Medicine. The web activity was also distributed by Elsevier via email blasts and via print and banner ads to their emergency medicine and critical care journal subscribers.

This activity expired for credit on December 17, 2014

 

OUT WITH THE OLD? IN WITH THE NEW? BAD BUGS, NEW DRUGS, AND ANTIMICROBIAL STEWARDSHIP

This live, interactive CME satellite symposium, presented at IDWeek™ 2014, included didactic lectures and in-depth moderated Q&A between attendees and faculty focusing on optimal treatment strategies for the management of hospital-acquired infections frequently associated with MDROs and new and emerging treatment aligned with the tenets of antimicrobial stewardship. The enduring web monograph, developed from the proceedings of the live symposium, was hosted on the Paradigm website, www.paradigmmc.com, and distributed via Paradigm and Elsevier on the MEDLINE-indexed American Journal of Infection Control website, as well as other appropriate web portals.

This activity expired for credit on January 19, 2016

 

CUTTING THROUGH COMPLEXITY: STRATEGIES FOR MANAGING COMPLICATED INFECTIONS

This live CME-certified activity was held as a satellite symposium during the ICAAC Scientific Sessions. In collaboration with the University of Cincinnati Medical School and Massachusetts College of Pharmacy, this activity was designed to help clinicians cut through the complexity of the management of complicated skin/skin structure and intra-abdominal infections to insure appropriate use and optimal selection of antimicrobial therapy for improved patient outcomes.

 

HARNESSING THE POWER OF INTRALESIONAL THERAPY FOR UNRESECTABLE MELANOMA

This live, interactive symposium, comprising didactic lectures, challenging real-world clinical cases, and a question-and-answer session with the faculty panel, was held as an ancillary symposium at the 2013 ASCO Annual Meeting and Exhibition. The enduring, on-demand web activity was based on the proceedings of the live symposium, hosted on www.realcme.com, and distributed via the Epocrates/MDLinx mobile and online networks. A link was also placed on Paradigm's website, www.paradigmmc.com, and the activity was promoted to Paradigm's internal database of oncology professionals.

This activity expired for credit on September 5, 2014

 

ADVANCES IN IMMUNOTHERAPY FOR ADVANCED MELANOMA: INTEGRATING INTRALESIONAL AND ANTI-PD-1 IMMUNOTHERAPIES INTO CURRENT PRACTICE

This CME-certified satellite symposium at the Society of Surgical Oncology (SSO) 2015 Annual Meeting included didactic presentations, interactive case presentations, and a moderated Q&A discussion with the faculty panel. Throughout the symposium, attendees used iPads to view the program, take notes, interact with faculty, and complete the posttest, increasing audience interaction. An enduring audio webinar based upon the proceedings of the live symposium is hosted on www.paradigmmc.com.

This activity expired for credit on May 22, 2016

 

4TH INTERNATIONAL SYMPOSIUM ON CANCER METASTASIS AND THE LYMPHOVASCULAR SYSTEM: BASIS FOR RATIONAL THERAPY

This 2.5-day multigrantor CME-certified conference in New York, NY, chaired by Stanley P. L. Leong, MD, FACS, featured dozens of world-renowned cancer experts. It was designed to help participants improve their expertise in detecting and managing cancer metastasis from its inception in the tumor microenvironment through its progression to metastatic potential at distant sites by way of the lymphovascular system. In collaboration with the Sentinel Node Oncology Foundation/Sentinel Lymph Node Working Group and Sutter Pacific Medical Foundation, the conference was also sponsored by the National Cancer Institute, The Arizona Cancer Center, AIM at Melanoma, and The Melanoma Research Foundation.

 

PROMISING NEW THERAPIES IN KIDNEY CANCER: UPDATE AND PANEL DISCUSSION

This CME satellite symposium at The Oncology World Congress was jointly sponsored with the Elsevier Office of Continuing Medical Education. It provided an overview of the latest data on key promising agents in kidney cancer as well as a panel discussion in which experts put these promising therapies into context. The target audience included community oncologists, pediatric oncologists, radiation oncologists, surgical oncologists, and urologists.

 

BRIDGING AVAILABLE TREATMENTS TO BEST-CASE OUTCOMES IN MELANOMA

This satellite symposium was presented in collaboration with the University of Pittsburgh School of Nursing at the 33rd Annual Oncology Nursing Society Congress. Chaired by Rosemary Giuliano, ARNP, MSN, and featuring John M. Kirkwood, MD, this interactive, case-based symposium focused on the oncology nurse's pivotal role in helping manage patient expectations, keeping patients on therapy, and guiding patients and their families through care decisions, including end-of-life issues.

 

PREVENTION AND MANAGEMENT OF DIABETIC RETINOPATHY AND RELATED EYE DISORDERS: CLARIFYING THE ENDOCRINOLOGIST'S ROLE

Diabetic retinopathy (DR) is a common microvascular complication of diabetes and the leading cause of blindness among working-age adults. Recent treatment advances that target vascular endothelial growth factor and inflammation have allowed patients with DR to stabilize vision - and, in many cases, regain some of their lost vision. Unfortunately, many patients with diabetes fail to receive recommended eye care that would allow for detection and treatment of DR early enough to optimize outcomes among patients with this disease, which is progressive without treatment. This educational activity will increase awareness of the widespread problem of low adherence to recommended diabetic eye care, the importance of suspecting diabetic eye problems (and referring to/partnering with eye care specialists), and the potential of newer agents to improve visual acuity. The critical importance of regular eye screenings to detect early retinal damage, which is typically asymptomatic, will be underscored.

This activity expired for credit on September 1, 2016

 

CLARIFYING THE ROLE OF NOVEL AND EMERGING TREATMENTS FOR DIABETIC RETINOPATHY AND RELATED EYE DISORDERS

This live, interactive, CME-certified symposium will be held at the AAO 2015 Annual Meeting, November 14-17, 2015 and will incorporate didactic lectures, interactive patient case studies, videos of injection techniques, and in-depth moderated Q&A between attendees and faculty. Throughout the symposium, attendees will use iPads, provided by Educational Measures, to view the program, take notes, and interact with faculty. An enduring, text-based, interactive web monograph, including links to relevant audio and video from the live ancillary symposium, will be hosted on the Paradigm website, www.paradigmmc.com, and distributed via Paradigm as well as Healio's Ophthalmology Education Lab website, www.healio.com/ophthalmology, online home of Ophthalmic Surgery, Lasers and Imaging and Retina and Ocular Surgery News.

This activity expired for credit on January 29, 2017

 

OPTIMIZING CARE TO IMPROVE OUTCOMES FOR PATIENTS WITH COPD

This live satellite symposium, held in conjunction with Internal Medicine 2014, provided an update on the recent updates to guidelines and therapies, as well as current evidence-based information about the CMS Core Measures as the prevention of a hospital admission has a direct effect on minimizing hospital readmission.

This activity expired for credit on April 9, 2014

 

RACE AGAINST THE CLOCK: OVERCOMING CHALLENGES IN THE MANAGEMENT OF ANTICOAGULANT-ASSOCIATED INTRACEREBRAL HEMORRHAGE

This audience-interactive CME satellite symposium was presented at the 81st Neurological Surgeons (AANS) Annual Scientific Meeting, April 27-May 1, 2013. An enduring peer-reviewed publication featured highlights of the live meeting and was distributed as a ride-along supplement in the Journal of Neurosurgery. The digital publication was located on the Paradigm website, www.paradigmmc.com.

This activity expired for credit on July 31, 2015

 

TARGETED ORAL ANTICOAGULATION IN THE EMERGENCY DEPARTMENT: KEY FACTORS IN STROKE PREVENTION IN ATRIAL FIBRILLATION

This live, interactive CME satellite symposium presented at ACEP14 included didactic lectures and in-depth moderated Q&A between attendees and faculty, and focused on stroke prevention in atrial fibrillation from an emergency department perspective. An enduring web monograph was developed from the proceedings and was accessible via the Paradigm website, www.paradigmmc.com, as well as via the University of Cincinnati's CME website, www.cme.uc.edu; and the myCME website, www.myCME.com.

This activity expired for credit on January 29, 2016

 

TARGET-SPECIFIC ORAL ANTICOAGULATION: FOCUS ON VENOUS THROMBOEMBOLISM AND ATRIAL FIBRILLATION

This live, interactive CME satellite symposium presented at the American Heart Association (AHA) Scientific Sessions 2014 featured a moderated roundtable discussion among experts in thrombosis management and in-depth, moderated Q&A between attendees and faculty, and focused on optimal use of current and emerging oral anticoagulants for stroke prevention in atrial fibrillation and venous thromboembolism. An enduring CME/CPE on-demand video webinar developed from the proceedings of the live symposium is accessible via the Paradigm website, www.paradigmmc.com, Paradigm's cardiovascular-focused portal, and the myCME website, www.myCME.com.

This activity expired for credit on February 23, 2016

 

ANSWERING THE CALL: THE ROLE OF HEALTH-SYSTEM PHARMACISTS TO IMPROVE USE OF TARGET-SPECIFIC ORAL ANTICOAGULANTS

This live, interactive CPE symposium presented at ASHP Midyear 2014 included didactic lectures and in-depth moderated Q&A between attendees and faculty, focused on optimal use of target-specific oral anticoagulant. An enduring web monograph developed from the proceedings of the live symposium was hosted on the Paradigm Medical Communications, LLC website (www.paradigmmc.com) and the Power-Pak C.E. website (www.powerpak.com).

This activity expired for credit on March 20, 2016

 

TARGET-SPECIFIC ORAL ANTICOAGULATION IN CLINICAL PRACTICE: BREAKING NEWS, CONTEMPORARY VIEWS

This live, interactive CME satellite symposium included didactic lectures, interactive patient case studies, and in-depth moderated Q&A between attendees and faculty, as well as patient education information and a prescribing pocket guide, presented at Internal Medicine 2015. A CME-certified on-demand video webinar developed from the proceedings includes the patient education information and downloadable version of the prescribing pocket guide. The enduring webinar will be accessible via the Paradigm website, www.paradigmmc.com, Paradigm's cardiovascular-focused portal, and the myCME website, www.myCME.com

 

HOSPITALISTS ON THE FRONTLINE: PREVENTING AND MANAGING THROMBOEMBOLIC EVENTS

This live, interactive CME satellite symposium, presented at Hospital Medicine 2015, included didactic lectures, in-depth moderated Q&A between attendees and faculty, and patient education resources. An enduring web monograph developed from the proceedings features the most clinically relevant content and additional resources such as patient education materials. The interactive CME-certified web monograph is accessible via the Paradigm website, www.paradigmmc.com, the HQF website, and the website for The Hospitalist, www.the-hospitalist.org.

This activity expired for credit on March 31, 2015

 

ANTICOAGULATION THERAPY IN PRIMARY CARE: KEEPING YOUR FINGER ON THE PULSE OF CURRENT CLINICAL RECOMMENDATIONS

Atrial fibrillation (AF) is the most common and important cardiac arrhythmia encountered in clinical practice. Even with the availability in recent years of 4 non-warfarin oral anticoagulants (NOACs), many at-risk patients are not assessed or treated appropriately due in part to confusion about where these agents fit in clinical practice. Due to pharmacodynamic and pharmacokinetic differences among the agents, patient-specific risk factors such as renal clearance must be taken into consideration when prescribing an NOAC. This activity has been designed to help primary care clinicians identify at-risk patients with AF, conduct an evidence-based work-up, and develop individualized treatment plans that appropriately utilize newer therapies when indicated.

This activity expired for credit on December 30, 2016